EP3713928
Nýir bradýkínin B2 viðtakamótverkendur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.11.2018EP published:
12.1.2022EP application number:
18818992.2
EP translation filed:
15.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
22.11.2038Expiry date:
22.11.2026Next due date:
30.11.2026
Title in English:
NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTSLanguage of the patent:
English
Timeline
Today
23.11.2018EP application
12.1.2022EP Publication
15.3.2022Translation submitted
15.4.2022Registration published
22.11.2026Expires
Owner
Name:
Pharvaris Netherlands B.V.Address:
Leiden BioScience Park J.H. Oortweg 21, 2333 CH Leiden, NL
Inventor
Name:
GIBSON, ChristophAddress:
13189 Berlin, DE
Name:
SAUPE, JoernAddress:
14469 Potsdam, DE
Name:
AMBROSI, Horst-DieterAddress:
10319 Berlin, DE
Name:
HAUSTEDT, Lars OleAddress:
14612 Falkensee, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17203675Date:
24.11.2017Country:
EP
Classification
Categories:
C07D 401/14, C07D 405/14, C07D 413/14, C07D 401/04, C07D 417/14, A61P 25/28, A61P 29/00, A61P 11/06, A61K 31/5377, A61K 31/4709
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.11.2022
Expires: 22.11.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 23.11.2023
Expires: 22.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.11.2024
Expires: 22.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.11.2025
Expires: 22.11.2026
Payer: Árnason Faktor ehf.